Protein kinase CK2 in development and differentiation (Review)

  • Authors:
    • Claudia Götz
    • Mathias Montenarh
  • View Affiliations

  • Published online on: December 19, 2016     https://doi.org/10.3892/br.2016.829
  • Pages: 127-133
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Among the human kinomes, protein kinase CK2 (formerly termed casein kinase II) is considered to be essential, as it is implicated in the regulation of various cellular processes. Experiments with pharmacological inhibitors of the kinase activity of CK2 provide evidence that CK2 is essential for development and differentiation. Therefore, the present review addresses the role of CK2 during embryogenesis, neuronal, adipogenic, osteogenic and myogenic differentiation in established model cell lines, and in embryonic, neural and mesenchymal stem cells. CK2 kinase activity appears to be essential in the early stages of differentiation, as CK2 inhibition at early time points generally prevents differentiation. In addition, the present review reports on target proteins of CK2 in embryogenesis and differentiation.
View References

Related Articles

Journal Cover

February-2017
Volume 6 Issue 2

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Götz C and Montenarh M: Protein kinase CK2 in development and differentiation (Review). Biomed Rep 6: 127-133, 2017.
APA
Götz, C., & Montenarh, M. (2017). Protein kinase CK2 in development and differentiation (Review). Biomedical Reports, 6, 127-133. https://doi.org/10.3892/br.2016.829
MLA
Götz, C., Montenarh, M."Protein kinase CK2 in development and differentiation (Review)". Biomedical Reports 6.2 (2017): 127-133.
Chicago
Götz, C., Montenarh, M."Protein kinase CK2 in development and differentiation (Review)". Biomedical Reports 6, no. 2 (2017): 127-133. https://doi.org/10.3892/br.2016.829